Exclusive: Idaho Files Suit Against Purdue Pharma, Leaving Two States That Are On The Fence
- Idaho filed suit against OxyContin manufacturer Purdue Pharma and members of the Sackler family Monday, the state Attorney General’s Office told The Daily Caller News Foundation Wednesday.
- That leaves two states that have not filed suits against the drug company and accused it of contributing to the U.S. opioid crisis.
- Michigan and Nebraska have not confirmed plans to sue Purdue Pharma.
Idaho joined nearly all other states on Monday in filing suit against OxyContin manufacturer Purdue Pharma and alleging it played a role in the nation’s opioid crisis, the state Attorney General’s Office told The Daily Caller News Foundation Wednesday.
Idaho accused Purdue Pharma of deceptively “devising and executing what became one of the deadliest marketing campaigns in history” in the complaint.
“For two decades, Purdue and the Sackler Family campaigned for sweeping changes in the public’s and medical community’s perception of opioids, by both downplaying the risks associated with opioid use and aggressively encouraging much broader use of the drugs than medically necessary or appropriate,” the state Attorney General’s Office wrote. (RELATED: Congressman Recalls Witnessing Violent Chinese Protests At Tiananmen Square Anniversary Rally)
The suit also names eight members of the Sackler family who served on Purdue Pharma’s board as defendants.
“Between 1999 and 2017, Idaho’s opioid-related death rate nearly tripled. In 2015 alone, approximately 1.3 million opioid prescriptions were written in Idaho — nearly one prescription for every man, woman, and child in the State,” the state alleged in Monday’s complaint.
The Idaho Attorney General’s Office declined to comment on the litigation to TheDCNF and said it does not usually issue press releases when filing suit. The complaint is public and can be viewed at the bottom of the post.
California, Hawaii and Maine also filed lawsuits against OxyContin manufacturer Purdue Pharma Monday that were widely reported on.
Michigan and Nebraska are the only two states that have not confirmed plans to file suit against the drug manufacturer.
Michigan is seeking outside counsel to pursue opioid-related claims, The Wall Street Journal reported in May. Nebraska sought documents and information from manufacturers and distributors of prescription opioids in 2017 but has not opted to sue Purdue Pharma or members of the family who owns it.
That doesn’t mean entities within those states have not taken legal action against the company. Multiple Michigan counties have sued opioid manufacturers including Purdue Pharma, reported the Detroit Free Press. All four of Nebraska’s Indian nations had filed suit against drug companies including Purdue Pharma as of May 2018, reported the Lincoln Journal Star.
Nebraska Attorney General Doug Peterson, a Republican, asked smaller players like cities and counties not to sue Purdue Pharma in April 2018, saying such lawsuits could slow legal efforts by the state, reported the Lincoln Journal Star.
California, Hawaii, Idaho and Maine brought the number of suits in the last few years up to 48 states plus Washington, D.C., reported The Guardian. Many of those suits also name members of the Sackler family who have served as decisionmakers at Purdue Pharma.
Purdue Pharma continued to deny the allegations of deceptive marketing and said it will “defend itself against these misleading attacks” in a statement to TheDCNF. The company also pointed to a favorable May 10 ruling when a state-court judge dismissed North Dakota’s suit against Purdue Pharma.
“The reality is that Purdue has no control over its product after it is sold to distributors, then to pharmacies, and then prescribed to consumers, i.e. after it enters the market,” South Central District Judge James Hill wrote according to WSJ.
North Dakota Attorney General Wayne Stenehjem, a Republican, plans to appeal the ruling.
States filed OxyContin-related suits against Purdue Pharma as early as 2004. West Virginia accused Purdue Pharma of deceptive marketing that year. The company avoided trial by agreeing to pay $10 million over a four-year period to the state’s drug abuse and education programs.
West Virginia initiated a second round on May 16 when it launched another suit against Purdue Pharma after a joint investigation with Kansas, Iowa, Maryland and Wisconsin that began in 2017.
“Purdue Pharma didn’t change its ways,” West Virginia Attorney General Patrick Morrisey, a Republican, said May 16.
In addition to the suits brought by the state attorneys general, more than 1,500 lawsuits were consolidated before a federal judge in Ohio with an expected October trial date if the parties do not settle beforehand.
Send tips to firstname.lastname@example.org.
Content created by The Daily Caller News Foundation is available without charge to any eligible news publisher that can provide a large audience. For licensing opportunities of our original content, please contact email@example.com.